[Form 3] PureCycle Technologies, Inc. Initial Statement of Beneficial Ownership

Rhea-AI Filing Summary

PureCycle Technologies (PCT) director Siri Jirapongphan filed a Form 3 initial beneficial ownership statement. The filing lists Series B Convertible Perpetual Preferred Stock with a $14.02 conversion price and notes the security is perpetual with no expiration.

The explanation states Dr. Jirapongphan purchased 300 shares of Series B at $1,000 per share for an aggregate $300,000. The Series B is convertible into common stock at a rate equal to the sum of $1,000 plus in‑kind and accrued dividends divided by the conversion price. The table reflects a date exercisable of 06/20/2025 and direct ownership.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Jirapongphan Siri

(Last) (First) (Middle)

C/O PURECYCLE TECHNOLOGIES, INC.

20 NORTH ORANGE AVENUE STE 106

(Street)

ORLANDO FL 32801

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
10/28/2025

3. Issuer Name and Ticker or Trading Symbol
PureCycle Technologies, Inc. [ PCT ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Series B Convertible Perpetual Preferred Stock	06/20/2025	(1)	Common Stock	(2)	$14.02	D

Explanation of Responses:

1. The Series B Convertible Perpetual Preferred Stock is perpetual and therefore has no expiration date.

2. Dr. Jirapongphan purchased 300 shares of the Series B securities at an initial issue price of $1,000 per share, for an aggregate purchase price of $300,000. The Series B Convertible Perpetual Preferred Stock is convertible into shares of Common Stock of the issuer at a conversion rate equal to (a) the sum of $1,000 plus in kind dividends plus accrued dividends divided by (b) the conversion price.

Remarks:

Exhibit 24 - Power of Attorney

	/s/ Brad S. Kalter as attorney-in-fact for Siri Jirapongphan	11/06/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did PureCycle (PCT) disclose in this filing?

A Form 3 initial statement of beneficial ownership by director Siri Jirapongphan.

What security does the PCT director beneficially own?

Series B Convertible Perpetual Preferred Stock, directly owned.

How many Series B shares and at what price were they acquired?

Dr. Jirapongphan purchased 300 shares at $1,000 per share, totaling $300,000.

What is the conversion price for the Series B into common stock?

The filing lists a $14.02 conversion price for conversion into common stock.

How is the conversion rate determined?

Conversion equals ($1,000 + in‑kind dividends + accrued dividends) ÷ conversion price.

Does the Series B have an expiration date?

No. It is perpetual and therefore has no expiration date.

What key dates are included?

The table shows a date exercisable of 06/20/2025 and the event date is 10/28/2025.